YN001-004 in Patients With Coronary Atherosclerosis in Australia

NCT06700720 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Coronary Atherosclerotic Disease

Interventions

DRUG: Dose 1 YN001
DRUG: Dose 2 YN001
DRUG: Evolocumab

Sponsor

Beijing Inno Medicine Co., Ltd.